Evidence map›Paper›PMID 29483112›Full record

ArticleAntimicrobial agents and chemotherapy2018

Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay.

Katarina Niward, Linnea Ek Blom, Lina Davies Forsman, Judith Bruchfeld, Erik Eliasson, Thomas Schön, Erja Chryssanthou, Jakob Paues

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Variability in plasma rifampicin concentrations and role ofInfectious diseases (London, England) · 2024
    Article
  3. Nanotechnology as a tool to overcome the bariatric surgery malabsorption.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Katarina NiwardDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Linnea Ek BlomDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Lina Davies ForsmanDepartment of Medicine Solna, Unit of Infectious Diseases, Karolinska Institute, Stockholm, Sweden.
Judith BruchfeldDepartment of Medicine Solna, Unit of Infectious Diseases, Karolinska Institute, Stockholm, Sweden.
Erik EliassonDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Thomas SchönDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden tschon@hotmail.com.
Erja ChryssanthouDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Jakob PauesDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Karolinska Institutet · SELinköping University · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plasma tuberculosis drug activity (TDA) assay may be an alternative tool for therapeutic drug monitoring in resource-limited settings. In tuberculosis (TB) patients (

Indexed as

AdultAntibiotics, AntitubercularDrug MonitoringFemaleHumansIsoniazidMaleMycobacterium tuberculosisRifampinTuberculosis, PulmonaryAntibiotics, AntitubercularIsoniazidRifampinisoniazidMycobacterium tuberculosispharmacokineticsrifampin

Identifiers

PMID29483112
PMCPMC5923115
OpenAlexW2790694322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.